Diabetes indicators improve with use of health incentives, CDC study finds
By
Alicia Lasek
Nov 10, 2022
Incentivizing patients to follow a lifestyle modification program helps them to improve a full range of diabetes-related health measures, according to a new meta-analysis.
Clinical briefs for Monday, Nov. 7
By
Alicia Lasek
Nov 07, 2022
OIG: OSHA’s failed enforcement activities heightened risk of workplace virus exposure … Nearly half of states now use Medicaid to boost direct-care pay … Study in seniors shows four-fold jump in...
NIA funds $3.7M study of dementia and diabetes in U.S. Latinos
By
Alicia Lasek
Nov 01, 2022
A new study will examine how diabetes affects brain changes over time in adults with Hispanic ancestry.
Clinical briefs for Friday, Oct. 21
By
Alicia Lasek
Oct 21, 2022
Use peer mentoring, not a ‘diet of distraction’ to combat isolation in long-term care … Behavioral health drug prescriptions surged during pandemic, Medicare data show … Diabetes drugs linked to...
NIH: COVID rebound after Paxlovid may signal a strong immune response
By
Alicia Lasek
Oct 11, 2022
Patients who had rebound symptoms after taking Paxlovid showed a more robust immune response to SARS-CoV-2 than patients with no rebound, investigators reported.
CDC: Two booster shots cut severe COVID risk in nursing home residents by 74 percent
By
Alicia Lasek
Oct 03, 2022
Nursing home residents who received a second mRNA booster shot during omicron were much less likely to suffer severe COVID-19 outcomes than their peers who received only one dose, a new study shows.
LTC research hub to bring clinical trials to rural residents
By
Alicia Lasek
Sep 16, 2022
Nursing home operator Principle LTC and Care Access, a research organization, have launched a new research hub in Raleigh, NC, to provide rural residents access to clinical trials.
New COVID booster shot rollout expected near Labor Day: officials
By
Alicia Lasek
Aug 25, 2022
The FDA expects to soon authorize omicron-targeting shots. The White House is planning to distribute them as part of a fall vaccination campaign, federal officials say.
FDA nixes use of Parkinson’s drug Nuplazid for treating Alzheimer’s psychosis
By
Alicia Lasek
Aug 08, 2022
The Food and Drug Administration has decided not to approve an expanded use of the psychosis drug pimavanserin (Nuplazid) to treat patients with Alzheimer’s.
Seniors on common maintenance drugs face fewer COVID-19 risks, NIH study finds
By
Alicia Lasek
Apr 20, 2022
Drugs used regularly in the long-term care population may help prevent SARS-CoV-2 infection and poor COVID-19 outcomes, investigators say.